Abstract
Background and purposeIschemic stroke is a major cause of disability and death in the USA. Intravenous tissue plasminogen activator (t-PA) remains underutilized. With the development of newer intra-arterial reperfusion therapies,...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have